Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",19151,137,0.65 [0.37-1.15],0.1412520478945705
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19978,153,1.03 [0.61-1.76],0.9054952223064028
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19775,1137,1.09 [0.90-1.33],0.3801338344318784
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,19990,294,0.94 [0.64-1.38],0.7493876373806874
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19401,2831,1.08 [0.95-1.23],0.2198389107527698
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19390,2871,1.35 [1.19-1.53],2.026503376293814e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19813,855,1.24 [0.99-1.56],0.0606468251714521
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19931,66,1.44 [0.65-3.16],0.367910133848319
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,18135,888,1.35 [1.08-1.69],0.0084012979791076
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17479,973,1.62 [1.31-1.99],7.169068846438185e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,17309,197,1.25 [0.77-2.02],0.3707356581231372
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14051,1858,1.29 [1.10-1.50],0.0012537745279391
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,17252,326,2.02 [1.41-2.89],0.0001208604452007
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19981,1023,1.21 [0.98-1.49],0.0704736264495233
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,20064,368,0.79 [0.56-1.12],0.1843897071431157
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19354,716,1.07 [0.84-1.37],0.584848995589273
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,20000,986,1.21 [0.98-1.49],0.0755175832106044
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,19113,155,1.01 [0.59-1.71],0.979123841276758
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,20099,42,0.56 [0.21-1.54],0.2642107615803679
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19868,854,1.21 [0.96-1.52],0.0994339296936224
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19919,54,0.76 [0.31-1.87],0.5476800900407652
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,20039,98,1.14 [0.58-2.24],0.7028957663220841
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",20024,83,1.65 [0.81-3.36],0.1691522424215708
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,19027,389,1.10 [0.78-1.54],0.5885460881785034
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18869,231,1.35 [0.87-2.09],0.1815161612141229
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,19026,68,2.41 [1.14-5.07],0.0206396876732341
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,20082,58,0.96 [0.40-2.30],0.9267680072009244
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,20051,121,0.82 [0.45-1.49],0.5085394604374248
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral warts,19975,45,1.45 [0.55-3.84],0.4563905400061705
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19975,45,0.38 [0.15-0.96],0.039802878613782
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,19840,293,0.82 [0.55-1.21],0.3210372573321923
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,20040,42,0.80 [0.28-2.30],0.6831046449180744
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,20007,47,0.67 [0.25-1.82],0.4366799679253875
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,20061,102,0.65 [0.34-1.27],0.2079184443123028
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19780,1378,1.21 [1.01-1.44],0.0388782621431551
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of meninges,20098,26,0.82 [0.22-2.97],0.7573326730316058
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,20047,57,3.77 [1.81-7.84],0.0003890463871975
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,20086,64,1.20 [0.52-2.74],0.6661387084971304
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,20076,381,1.66 [1.20-2.31],0.002362863914735
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Caecum,20079,288,1.16 [0.79-1.71],0.452689442321914
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19988,63,0.98 [0.43-2.24],0.9557401138346012
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,20073,240,0.96 [0.62-1.48],0.851935500011159
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,20035,350,1.31 [0.92-1.87],0.128290420818414
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19994,631,1.13 [0.86-1.47],0.3788096523732889
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,20062,465,1.07 [0.79-1.45],0.6582779924028667
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",15659,64,0.81 [0.35-1.90],0.6353512840006392
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",15657,62,0.38 [0.16-0.90],0.0269271775110448
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",20071,80,0.31 [0.15-0.63],0.0011041154135553
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Haemangioma, any site",20071,77,0.57 [0.34-0.93],0.0248100366211778
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Lung cancer and mesothelioma,13405,302,1.02 [0.68-1.53],0.9250855906662374
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Lymphoid leukaemia,15653,58,0.91 [0.38-2.23],0.8448537589532433
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",15754,159,0.98 [0.57-1.69],0.9514506717098816
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",15830,235,0.67 [0.43-1.05],0.080009416715663
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",15671,76,0.36 [0.17-0.78],0.0101335248091699
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",15710,115,1.87 [1.02-3.40],0.0413167978296359
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",15723,128,1.04 [0.57-1.88],0.9037618549912478
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",15662,67,0.99 [0.43-2.27],0.9873345166611844
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16741,1146,0.85 [0.70-1.04],0.1150401215943727
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",15716,121,1.31 [0.71-2.41],0.383803081641873
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",15690,95,1.10 [0.55-2.17],0.7896137324744262
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,15698,103,1.27 [0.65-2.46],0.4865072430191458
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanocytic naevi,19998,142,1.17 [0.67-2.04],0.5840630268209954
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanocytic naevi of trunk,20073,83,1.09 [0.52-2.27],0.8228021633198304
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanoma in situ,15623,63,0.44 [0.19-1.03],0.057208282196615
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",15684,89,0.51 [0.25-1.05],0.0675829486186904
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",15738,143,0.77 [0.43-1.35],0.3586323131899355
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",15790,195,0.93 [0.57-1.52],0.7818198361218044
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",15684,89,1.41 [0.70-2.84],0.3308482255365248
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Other benign neoplasms of skin,19991,123,1.04 [0.57-1.90],0.8981181099393014
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16602,1007,1.09 [0.88-1.35],0.4234613361632098
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",16662,1067,1.06 [0.86-1.31],0.5662478248810523
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19877,244,0.75 [0.49-1.15],0.1851719079958316
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,18675,65,3.53 [1.75-7.11],0.0004316356396718
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19689,56,0.69 [0.28-1.72],0.4274640507725925
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19657,2268,1.19 [1.04-1.37],0.0128258449568893
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,19066,51,1.23 [0.49-3.07],0.6641349898987012
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19746,43,1.89 [0.72-4.95],0.1950586415172677
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19807,1197,1.23 [1.02-1.49],0.0295851720747042
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19805,1195,1.23 [1.02-1.49],0.0318461574555074
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,18686,76,0.70 [0.33-1.51],0.3673624255020601
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19915,900,1.29 [1.04-1.61],0.0205566133447395
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19794,91,2.68 [1.44-4.97],0.0018214107268387
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19690,57,2.20 [0.96-5.07],0.0633990211209237
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19686,53,1.11 [0.45-2.78],0.81563520479507
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19961,258,1.43 [0.96-2.14],0.0809526794547814
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,20019,38,0.52 [0.17-1.57],0.2474144421496457
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19912,209,1.16 [0.73-1.82],0.531860777704011
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,19076,61,0.92 [0.40-2.12],0.8463681887122281
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,14899,300,1.74 [1.19-2.55],0.0042492456898758
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18379,131,0.86 [0.48-1.56],0.6278793949065687
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18409,161,1.05 [0.60-1.83],0.8766259662595421
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14650,51,1.71 [0.67-4.38],0.2595992578038233
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18977,54,0.55 [0.22-1.36],0.1935881183160173
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18328,188,0.89 [0.55-1.44],0.6429105227418247
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19710,473,1.03 [0.77-1.39],0.8267359113810355
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19433,196,0.84 [0.52-1.33],0.4541315852461276
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,19355,118,0.51 [0.28-0.92],0.0259742854261844
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19851,928,1.20 [0.97-1.50],0.0976890319404066
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17241,894,1.14 [0.91-1.43],0.2510557520632794
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14657,58,1.03 [0.42-2.52],0.94236325702212
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",19384,36,1.05 [0.35-3.17],0.9301271370141836
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,14813,214,2.26 [1.45-3.51],0.0002979520200702
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14659,60,0.86 [0.35-2.09],0.7344511293332403
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17819,3220,1.12 [0.99-1.26],0.0668117663589132
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,14748,149,0.74 [0.42-1.30],0.2908684045427367
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15050,451,1.34 [0.97-1.84],0.071279290751886
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,20050,221,2.01 [1.32-3.07],0.0011660118641129
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19899,70,7.91 [5.04-12.42],2.398633797645063e-19
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,14723,124,0.78 [0.42-1.45],0.433947377695137
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14654,55,1.19 [0.48-2.91],0.7093956473985843
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19945,597,1.49 [1.14-1.94],0.0035132473712739
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,14851,252,1.89 [1.26-2.84],0.002275257234529
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,14885,286,4.45 [3.28-6.04],1.2093443155291192e-21
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15202,603,1.27 [0.97-1.68],0.0831656133554021
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14711,112,1.54 [0.83-2.86],0.1718016833952781
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19893,64,8.58 [5.47-13.47],7.954694655780296e-21
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15089,490,1.10 [0.81-1.50],0.5408013298294722
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,14925,326,0.62 [0.42-0.90],0.0130466446407449
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,18188,48,1.74 [0.68-4.41],0.2454127885270915
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18932,4333,1.11 [1.00-1.23],0.0453568188296014
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,19360,12,5.33 [1.60-17.75],0.0064144750922688
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,19369,21,0.87 [0.20-3.85],0.853893897951379
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19963,1489,1.02 [0.86-1.21],0.8130450965921383
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19959,1484,1.02 [0.86-1.21],0.8207154319709942
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,19362,14,7.54 [2.50-22.71],0.0003318351884903
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19875,672,1.02 [0.78-1.32],0.9052331315031796
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15939,1340,1.25 [1.04-1.50],0.015708274861425
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,20090,198,2.23 [1.44-3.45],0.0002967608570681
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,19321,84,1.06 [0.51-2.19],0.8705583593353423
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,19265,62,0.98 [0.42-2.29],0.9703998204377472
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,19276,73,0.87 [0.40-1.88],0.7212650018542922
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",14657,58,3.22 [1.50-6.93],0.0027891993755676
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17752,144,1.91 [1.12-3.29],0.0184245479917189
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2132,103,1.97 [1.09-3.57],0.0256420305117091
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2268,265,0.73 [0.49-1.08],0.1185854755107894
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17690,82,1.77 [0.87-3.63],0.1166091753865456
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2085,56,6.92 [3.77-12.72],4.69343976018999e-10
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19456,1848,0.96 [0.82-1.12],0.5893756598342197
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19511,274,1.11 [0.75-1.64],0.6051085545924433
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18338,198,0.96 [0.60-1.55],0.8820595862682264
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15232,633,1.37 [1.05-1.79],0.0188646884313233
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19991,207,1.63 [1.04-2.55],0.0323898248801866
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),19095,231,1.17 [0.76-1.81],0.4758209370168431
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,17691,1240,1.08 [0.90-1.31],0.4095404710521404
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,19191,327,1.14 [0.79-1.64],0.4986093790393232
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18929,65,1.43 [0.62-3.28],0.3967008318847046
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",19053,189,2.00 [1.26-3.18],0.0032272097026684
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11778,1911,1.07 [0.92-1.25],0.3870683449387003
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,AV-block,16218,501,0.97 [0.72-1.30],0.8171057936381627
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",20040,435,1.01 [0.74-1.39],0.9424194481027562
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,10078,211,2.30 [1.51-3.52],0.0001093211047878
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15887,170,1.37 [0.82-2.29],0.233496360505691
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",15807,90,1.96 [0.99-3.89],0.0548101388063746
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,20099,48,0.99 [0.39-2.47],0.9759583447316384
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,16842,1125,1.11 [0.91-1.35],0.2993674894514995
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18636,2205,1.14 [0.99-1.31],0.0711073714808829
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17013,6585,1.07 [0.98-1.16],0.1425571009908647
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,19061,228,1.64 [1.07-2.52],0.0244829513787402
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Endocarditis,15787,70,0.52 [0.23-1.17],0.1157328308252795
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19836,1107,1.24 [1.02-1.51],0.0286448349099866
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypertension,18012,5720,1.18 [1.08-1.29],0.0003543027538529
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",18017,5725,1.18 [1.08-1.29],0.0003151200993626
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19903,99,0.82 [0.42-1.58],0.5509878760291931
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12463,171,2.89 [1.86-4.50],2.438947264993497e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12397,105,11.81 [8.64-16.12],2.3210925086864006e-54
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypotension,19976,996,1.28 [1.04-1.57],0.0209021964561662
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,19218,97,0.90 [0.46-1.78],0.7706176109455163
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18752,2301,1.12 [0.97-1.28],0.1163830517111872
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19755,548,1.40 [1.06-1.85],0.0182132484201633
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,16060,343,1.36 [0.95-1.94],0.0905473989088959
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19515,896,1.07 [0.85-1.33],0.57398248658039
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",17228,777,1.13 [0.89-1.44],0.3017190935744977
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19962,194,1.36 [0.85-2.18],0.2040825254050501
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",20056,315,0.94 [0.64-1.36],0.7364950500166527
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,18887,54,0.89 [0.36-2.19],0.795104528343237
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other aneurysm,18943,79,1.26 [0.60-2.66],0.5465286767182354
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,16121,404,1.14 [0.82-1.59],0.4428953332766857
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18971,107,1.36 [0.71-2.60],0.3507346523284832
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,19087,223,1.57 [1.02-2.42],0.0424222197181459
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,15873,156,1.12 [0.65-1.91],0.6885571529288088
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,18910,77,0.91 [0.42-1.95],0.8064822110842351
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18875,42,1.41 [0.51-3.90],0.5097467993004616
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18810,73,1.85 [0.88-3.89],0.1063641299980212
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18920,87,1.06 [0.52-2.15],0.8732132700294551
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16749,1032,1.31 [1.06-1.60],0.0105738970314458
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,19035,55,1.74 [0.72-4.17],0.2172199481634685
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19332,468,1.40 [1.03-1.89],0.0303466737257855
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19557,320,1.91 [1.36-2.70],0.0002267798537787
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19277,540,1.12 [0.84-1.48],0.4431813151664177
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,10177,310,1.24 [0.84-1.82],0.2768500117312534
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19250,429,1.34 [0.98-1.84],0.068556594294996
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),19125,292,1.16 [0.78-1.71],0.4660998476427778
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19647,410,1.17 [0.84-1.62],0.3476492437135283
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,20047,589,1.25 [0.96-1.63],0.1007079720809897
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,16113,396,1.07 [0.76-1.49],0.7034066938909542
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19556,319,1.90 [1.35-2.69],0.000264989039305
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18918,181,0.79 [0.48-1.31],0.3642685756600836
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19743,622,1.36 [1.05-1.77],0.0201650759445526
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19732,646,1.37 [1.06-1.78],0.0154028527541514
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,19201,37,1.86 [0.65-5.34],0.250652218809397
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18958,95,1.58 [0.80-3.10],0.1864071199390474
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19403,196,1.57 [0.99-2.50],0.0531338763416973
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18876,257,0.86 [0.57-1.30],0.4726869688581835
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Varicose veins,19153,320,0.83 [0.57-1.20],0.3241969872879933
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18880,59,1.46 [0.62-3.44],0.3859653631513257
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19890,641,1.10 [0.85-1.43],0.4670945745079438
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19931,415,0.90 [0.65-1.26],0.5401102131526444
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17332,813,1.05 [0.83-1.34],0.6728132000975476
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Any mental disorder,19519,3000,0.96 [0.85-1.09],0.5698883446761797
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19878,483,0.91 [0.67-1.23],0.5281601990335762
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17479,960,1.10 [0.89-1.37],0.3884208008181959
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16582,63,0.84 [0.36-1.96],0.682477188816518
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Smoking dependency,19541,1287,0.91 [0.75-1.10],0.3411989152308569
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18077,1558,0.92 [0.77-1.10],0.3361950402025395
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Vascular dementia,19714,116,0.85 [0.47-1.54],0.5934513148822247
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Alzheimer disease,20099,245,1.03 [0.68-1.56],0.8862185304384012
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",13465,49,0.49 [0.19-1.26],0.1407979289900148
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Bell's palsy,18950,67,1.36 [0.61-3.03],0.4580187464078037
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,19174,291,0.92 [0.62-1.35],0.6628489451840667
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Cerebral cysts,19765,190,1.02 [0.63-1.66],0.9217176559423432
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,20027,287,1.20 [0.81-1.77],0.362073240715249
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19695,55,0.83 [0.34-2.02],0.6823698411438305
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,20084,66,0.65 [0.29-1.47],0.2986409068374711
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19649,74,0.63 [0.29-1.37],0.2463727773378874
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Epilepsy,18762,234,1.07 [0.69-1.65],0.7718370024678389
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19653,1125,1.44 [1.19-1.75],0.0002372516595181
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,20066,397,0.54 [0.39-0.75],0.0002199022485416
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19638,1779,1.07 [0.91-1.25],0.3973504726731905
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,19778,49,0.46 [0.18-1.22],0.1182484473880308
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Hemiplegia,19963,223,1.23 [0.79-1.90],0.3616233294815751
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Hydrocephalus,19624,49,1.23 [0.48-3.16],0.6711027319515378
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,20084,53,2.49 [1.06-5.83],0.0353700397055521
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18902,19,0.76 [0.41-1.42],0.3944404479311925
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18960,77,1.08 [0.51-2.30],0.837890688897384
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Memory loss,19583,105,0.96 [0.50-1.83],0.9016232485284482
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Migraine,18689,161,1.98 [1.19-3.29],0.0085541675010261
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",20081,147,2.29 [1.36-3.84],0.001705620379274
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Motor neuron disease,13567,139,1.28 [0.72-2.28],0.3940099138576949
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19997,59,1.46 [0.60-3.56],0.4003183824705523
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19696,813,1.03 [0.81-1.30],0.8279962978334405
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Neurological diseases,18984,2964,1.03 [0.91-1.17],0.5892466582500834
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19824,184,0.83 [0.51-1.35],0.4611166097357323
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",19193,310,0.76 [0.52-1.11],0.1498917018471364
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",20024,296,1.04 [0.71-1.53],0.830017478177608
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15880,509,0.95 [0.71-1.29],0.7599616972186022
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19635,60,0.97 [0.41-2.31],0.9440269706811584
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19700,125,0.78 [0.43-1.41],0.4027743213456495
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19779,110,0.55 [0.30-1.04],0.0644322690755884
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18967,84,1.44 [0.70-2.94],0.3227466725482422
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other headache syndromes,18562,34,0.69 [0.22-2.17],0.529405589202511
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,20001,426,0.92 [0.66-1.27],0.6030755477685904
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,19107,579,1.54 [1.17-2.01],0.0017285388740018
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Parkinson's disease,20078,267,0.49 [0.33-0.73],0.0003546472201756
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19598,23,2.36 [0.64-8.66],0.1965199352559411
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,20098,37,0.47 [0.16-1.36],0.162438095574965
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,19853,524,1.61 [1.22-2.13],0.0007854086963015
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19777,49,1.47 [0.58-3.70],0.4173815110329316
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,20082,158,1.09 [0.64-1.84],0.756457853940723
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18911,28,0.60 [0.18-2.07],0.4235220087632598
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,20099,248,1.01 [0.67-1.52],0.970979260944291
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),19686,112,0.86 [0.47-1.58],0.6269318740379617
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19656,69,0.72 [0.33-1.59],0.4153422636419376
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19807,241,0.90 [0.59-1.38],0.6419412562249782
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19949,247,0.60 [0.39-0.91],0.0170083705551726
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19357,40,0.76 [0.27-2.14],0.6012283371609084
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19371,54,1.27 [0.51-3.16],0.6129050835421076
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",20021,34,0.35 [0.12-1.03],0.0563222321414113
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19912,101,0.67 [0.35-1.28],0.2252158273365725
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2085,56,7.16 [3.93-13.04],1.1988956487866634e-10
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2539,108,1.80 [1.03-3.14],0.0382859546667518
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19667,80,1.54 [0.74-3.18],0.2477071101280232
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19911,843,0.81 [0.64-1.02],0.0693172444478949
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19841,524,1.06 [0.80-1.41],0.6878110981314014
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19430,113,0.98 [0.53-1.82],0.9571082780196633
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",20036,470,0.98 [0.72-1.33],0.8995376426576891
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,20097,55,1.48 [0.61-3.58],0.3854494910849499
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19984,418,0.98 [0.71-1.35],0.8967023947967284
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",20066,255,0.70 [0.47-1.07],0.097412537599426
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,20023,132,0.85 [0.48-1.52],0.592286023432503
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19384,67,2.15 [1.03-4.52],0.0426437765426015
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19393,76,0.67 [0.31-1.41],0.2883795627487963
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19351,34,0.77 [0.25-2.37],0.6476052095569839
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,20019,572,0.78 [0.59-1.03],0.07967403203795
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,19611,164,0.60 [0.37-1.00],0.0495352783560811
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19589,23,2.31 [0.66-8.14],0.1915208982460008
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19892,81,0.73 [0.35-1.53],0.408237749775764
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19990,179,0.72 [0.44-1.18],0.1914208975961824
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19716,150,1.02 [0.59-1.76],0.948259219729875
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19961,70,0.79 [0.36-1.75],0.5631819582810893
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19819,372,0.73 [0.52-1.02],0.0652051502149884
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19685,98,1.01 [0.52-1.98],0.9712483104528198
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18968,1494,1.07 [0.91-1.27],0.4139074748409763
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19966,155,0.68 [0.40-1.15],0.1505060741422544
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,20084,119,1.30 [0.72-2.36],0.3884530358308887
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19683,366,1.07 [0.76-1.50],0.7125134486194535
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19869,58,0.67 [0.28-1.60],0.3691950878181143
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,20087,45,1.05 [0.39-2.82],0.923022349012085
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19377,60,0.58 [0.25-1.36],0.2127358729391693
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19444,127,0.92 [0.51-1.65],0.7752596241452369
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,19174,106,0.45 [0.24-0.85],0.0134892736160197
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,19603,37,0.94 [0.31-2.83],0.9175599100701892
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",19123,55,0.41 [0.17-1.00],0.048851922098727
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19488,41,1.04 [0.37-2.89],0.9450676996791796
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19618,171,0.98 [0.59-1.61],0.9329746616023687
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19414,97,1.47 [0.77-2.79],0.2436372148000966
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,19175,107,0.91 [0.47-1.76],0.7882731334021315
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,19143,75,0.90 [0.42-1.94],0.7970244997423341
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,18675,1201,1.10 [0.91-1.32],0.3376493750135722
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19364,47,0.59 [0.23-1.54],0.2845407477325455
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19902,315,1.10 [0.76-1.60],0.6135687770207114
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19647,60,1.15 [0.50-2.68],0.7371384242314007
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19710,123,0.92 [0.51-1.68],0.7973103080636439
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19944,52,1.02 [0.41-2.56],0.9625308272502964
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,20063,108,1.19 [0.63-2.23],0.5888801754087026
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19984,95,2.29 [1.22-4.30],0.0099201717358867
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19937,45,1.79 [0.69-4.65],0.2286645294665006
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,19935,43,0.86 [0.31-2.37],0.7702213707366745
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,20014,787,1.23 [0.98-1.56],0.0764943520741535
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19811,584,1.19 [0.91-1.57],0.2002578590066299
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19334,107,1.30 [0.69-2.44],0.4170163784874822
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19297,70,0.89 [0.40-1.98],0.774918200769554
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,19913,46,1.67 [0.65-4.33],0.2883799741758469
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,20025,158,1.33 [0.79-2.25],0.2897442043077615
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19919,52,2.10 [0.89-4.97],0.0902124163725246
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,All influenza,18212,85,1.25 [0.61-2.57],0.5483393230448244
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),18209,82,1.32 [0.63-2.75],0.4621406915059781
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),13189,86,1.89 [0.92-3.88],0.0821418387553325
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,20011,230,0.67 [0.43-1.06],0.0845506183553606
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14030,1216,0.98 [0.80-1.20],0.8510071486063718
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14295,1192,0.97 [0.79-1.18],0.7508044018230701
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19766,123,0.97 [0.54-1.75],0.9190041377313763
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",18202,75,1.12 [0.52-2.40],0.7734536702635736
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Bronchiectasis,17455,244,1.03 [0.68-1.56],0.906263542826289
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",17247,36,1.74 [0.60-5.05],0.3109344535923756
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19373,2162,1.05 [0.91-1.21],0.4977935605906447
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18864,66,0.87 [0.38-1.98],0.7341895147563591
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,18927,129,0.97 [0.54-1.76],0.9292220573839052
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19910,1097,1.07 [0.88-1.31],0.483249582718668
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,18922,124,0.85 [0.46-1.59],0.6168507442730261
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18392,4411,1.00 [0.91-1.11],0.9550524621900518
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",19137,339,0.94 [0.65-1.36],0.752587874207332
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Early onset COPD,19084,271,0.98 [0.65-1.49],0.9380521424811352
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Emphysema,17518,307,1.12 [0.77-1.64],0.5438916505436892
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19299,301,1.15 [0.79-1.67],0.4611776379529123
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19889,1762,1.05 [0.89-1.23],0.572174340140471
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,19321,323,1.18 [0.82-1.70],0.3629864773608747
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Later onset COPD,19158,826,1.06 [0.85-1.33],0.6140959461817936
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,20083,331,1.20 [0.84-1.71],0.3277096252268632
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Nasal polyp,18929,131,0.82 [0.46-1.49],0.5214242292960677
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19866,815,1.20 [0.95-1.51],0.1266650051883958
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,19866,1839,1.14 [0.97-1.33],0.1027279611927732
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19543,745,0.86 [0.67-1.10],0.2160081390832463
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other pleural conditions,18077,50,0.57 [0.22-1.47],0.2458964375764704
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,20004,393,1.37 [0.99-1.89],0.0554852836022005
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19997,1171,1.13 [0.93-1.37],0.2176899541265766
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pleural effusion,18954,927,1.30 [1.05-1.61],0.0172801268516846
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pleural plaque,18252,225,1.00 [0.64-1.55],0.9965334189580576
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19677,1550,1.05 [0.89-1.24],0.5694429779076623
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19997,245,1.28 [0.84-1.94],0.2494074198538984
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pneumothorax,18148,121,0.89 [0.48-1.65],0.7158290435363619
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pollen allergy,20085,199,0.65 [0.40-1.06],0.0850459430250351
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,19668,57,2.20 [0.97-4.98],0.0597083732173872
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,13154,51,0.99 [0.38-2.59],0.986316995316478
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19850,799,1.16 [0.92-1.46],0.2129244432935941
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,19029,231,0.68 [0.43-1.06],0.089329470797351
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Viral pneumonia,18350,223,1.22 [0.78-1.91],0.3786127876695794
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19786,190,1.42 [0.89-2.28],0.1444640106221065
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,8805,96,1.13 [0.56-2.30],0.734142834524652
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14080,72,1.23 [0.55-2.72],0.6120189205156881
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,19988,118,1.21 [0.65-2.24],0.5515129376064036
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute gastritis,15228,72,2.55 [1.26-5.17],0.0095324919218001
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,18945,173,1.23 [0.74-2.04],0.4168843387837454
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute peritonitis,19791,78,1.57 [0.76-3.26],0.220869508366679
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19339,94,1.32 [0.66-2.63],0.4334643426146999
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,15599,443,1.17 [0.85-1.60],0.3311976563876675
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",18875,103,1.40 [0.73-2.65],0.3095091458982605
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19758,103,1.38 [0.73-2.63],0.3232369996703621
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Cholecystitis,18957,185,1.25 [0.77-2.03],0.3728388184143051
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,19459,687,1.45 [1.13-1.86],0.0031731904835304
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,15376,220,0.76 [0.49-1.20],0.2388207447469185
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,18819,47,0.81 [0.31-2.15],0.6741202969614193
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19923,119,1.18 [0.65-2.15],0.583250254201513
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Coeliac disease,18731,74,0.53 [0.24-1.15],0.1093592529702448
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Collagenous colitis,18883,40,0.98 [0.34-2.86],0.9731004290036176
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19956,183,0.95 [0.58-1.56],0.8351771909195377
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Constipation,19958,1299,1.04 [0.86-1.24],0.7111931847117414
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Crohn disease,18919,76,0.71 [0.32-1.54],0.3804320056241108
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19807,55,0.53 [0.22-1.29],0.1624194946738232
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18907,64,0.92 [0.39-2.15],0.8434337124647875
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Dental caries,19556,185,1.26 [0.77-2.06],0.3569381499916434
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17035,1628,0.99 [0.84-1.17],0.940104413362232
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,20013,143,1.07 [0.61-1.89],0.8076880909342229
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of liver,19980,735,1.04 [0.82-1.34],0.7297931438582759
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18406,3250,1.09 [0.97-1.22],0.1616228834163395
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19791,420,1.05 [0.76-1.46],0.7728576981530151
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,20061,348,1.08 [0.75-1.54],0.6905897838214923
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19458,87,0.90 [0.43-1.86],0.7720635421922756
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19348,51,1.47 [0.58-3.71],0.4189476311510057
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19834,1177,1.16 [0.96-1.41],0.1314504403108524
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of tongue,19357,93,1.51 [0.77-2.99],0.2338573506339846
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19803,1031,1.30 [1.06-1.59],0.0127788616405112
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16580,2572,1.21 [1.06-1.38],0.0043413208728204
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,15370,214,1.80 [1.16-2.79],0.0085522508828838
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19998,166,1.24 [0.75-2.07],0.405241163080959
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,20042,34,0.75 [0.23-2.44],0.6379541731899209
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19382,137,1.23 [0.70-2.15],0.4716490978470498
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14156,148,0.87 [0.50-1.53],0.636470538552398
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,15508,352,0.97 [0.67-1.38],0.849256824371181
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,15462,306,0.91 [0.62-1.33],0.6226253376932844
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16954,1798,1.11 [0.95-1.30],0.2033913307982418
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15646,490,1.11 [0.82-1.49],0.5020734726652816
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15372,6690,1.02 [0.94-1.11],0.6003449672619193
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,GI-bleeding,19631,974,1.22 [0.99-1.51],0.0614019085724083
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19416,45,1.18 [0.43-3.19],0.7501817599407952
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,14790,1015,1.13 [0.91-1.39],0.2722700943314732
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19316,71,1.76 [0.82-3.79],0.1470720108554834
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Hernia,18364,2957,0.86 [0.76-0.97],0.0160570499727274
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Impacted teeth,20045,33,0.84 [0.26-2.78],0.77939593434602
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Impaction of intestines,14046,38,0.69 [0.24-2.00],0.4897605553683725
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,16784,1377,0.74 [0.62-0.89],0.0012710901810943
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15570,163,0.53 [0.31-0.90],0.0182467678669514
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14083,75,1.29 [0.60-2.76],0.5152040687442994
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18744,87,0.72 [0.35-1.48],0.3658732367377638
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14243,235,1.03 [0.66-1.61],0.8808247312820695
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,20062,315,0.91 [0.62-1.33],0.6184433040799463
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19410,567,1.37 [1.04-1.81],0.0253709521069129
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19588,745,1.24 [0.97-1.58],0.0816465235502853
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15331,175,1.42 [0.87-2.33],0.1605670217364737
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oesophagitis,15682,526,1.10 [0.82-1.47],0.5170626378278057
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,20051,94,1.29 [0.65-2.56],0.4669214112063206
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15464,57,1.11 [0.46-2.65],0.8154696444156164
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15212,1204,1.01 [0.84-1.23],0.8812474443005359
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18990,218,0.98 [0.62-1.53],0.9194793617566052
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,18875,103,1.16 [0.60-2.24],0.662387190870894
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,15597,1589,1.15 [0.98-1.36],0.0941712136681583
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,18559,4551,1.10 [1.00-1.22],0.0546404463741953
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19328,153,1.06 [0.62-1.82],0.8363565244477683
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,19835,590,1.06 [0.81-1.40],0.6761485920859174
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15776,620,1.02 [0.78-1.34],0.8631243158455613
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,18885,113,1.60 [0.88-2.94],0.1266104568844163
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,20004,291,0.98 [0.66-1.45],0.908217793482249
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15821,665,1.30 [1.01-1.68],0.0406214555931775
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19640,983,1.23 [1.00-1.52],0.0513927608069951
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19516,145,1.22 [0.71-2.12],0.4743414146450436
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,15337,1329,1.06 [0.89-1.27],0.5214630789737831
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),16724,1568,1.12 [0.95-1.32],0.1907571405079199
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19325,80,0.75 [0.36-1.58],0.4489595423194915
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19493,650,1.28 [0.99-1.66],0.0626099489617366
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14299,291,0.97 [0.66-1.43],0.8640990544457013
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,20033,42,0.96 [0.34-2.75],0.9432328037555826
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14402,394,1.00 [0.72-1.40],0.9855757376756832
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18799,142,1.01 [0.58-1.76],0.982100603057053
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,20085,34,0.59 [0.34-1.05],0.074292049354442
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19376,80,0.53 [0.25-1.14],0.1050075003681976
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Toxic colitis,18881,38,1.51 [0.54-4.25],0.4354918480856566
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15414,258,1.23 [0.82-1.86],0.3175393154792377
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,18969,126,1.15 [0.64-2.09],0.6390039167329031
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18947,104,0.88 [0.45-1.72],0.7117168862591224
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,15708,301,0.73 [0.49-1.08],0.1110639311054766
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14139,131,1.15 [0.65-2.03],0.6413645821348952
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ventral hernia,15623,216,0.75 [0.47-1.18],0.2090802330651407
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Volvulus,14066,58,1.16 [0.49-2.78],0.7334659918241485
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,20045,273,0.83 [0.56-1.25],0.372463601809438
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19835,58,2.14 [0.95-4.84],0.0663126261179028
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18465,76,0.68 [0.31-1.47],0.32679273028861
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19476,639,1.27 [0.98-1.65],0.0740546472622875
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",19007,170,1.20 [0.71-2.03],0.4857704044992269
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,18753,364,0.87 [0.61-1.22],0.4136969127021214
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19854,226,1.60 [1.04-2.45],0.0333906339796745
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,20016,388,1.13 [0.80-1.58],0.4926409155326455
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19667,39,1.13 [0.39-3.27],0.8286443953679419
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18835,2627,1.05 [0.92-1.19],0.5046289989887818
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19711,335,0.74 [0.51-1.06],0.1041917261228406
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19613,237,0.66 [0.43-1.02],0.0607442422300309
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19701,864,1.25 [1.00-1.57],0.0508950576317983
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",20089,24,0.66 [0.17-2.55],0.5450646783105502
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,18412,23,0.82 [0.20-3.43],0.789482194196968
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19428,52,1.13 [0.46-2.76],0.7908787230317349
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19850,222,1.63 [1.06-2.52],0.0272042213230157
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18789,400,0.91 [0.65-1.27],0.5670074157729188
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,18455,66,0.74 [0.32-1.69],0.471779312777141
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,20042,71,1.78 [0.83-3.81],0.139842615670487
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,19003,166,0.84 [0.50-1.41],0.4998678588864425
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19957,180,1.30 [0.80-2.13],0.289225727573735
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19686,58,0.87 [0.36-2.09],0.7597830267426475
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,18442,53,0.75 [0.30-1.90],0.5451806847173157
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19715,1326,0.87 [0.73-1.05],0.146579642378797
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18824,435,0.87 [0.63-1.20],0.3862252952951552
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,18458,69,0.67 [0.30-1.51],0.3385692450855511
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,20024,247,1.39 [0.92-2.10],0.1212463322005402
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19671,43,0.89 [0.32-2.45],0.8152481509701334
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19994,217,1.52 [0.98-2.37],0.0617907626429615
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,20061,289,0.85 [0.58-1.26],0.4251118789211012
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18461,72,0.64 [0.29-1.42],0.2726947376435576
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18610,221,0.61 [0.39-0.96],0.0321103875106899
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,20055,283,0.88 [0.59-1.30],0.5206612584797521
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18597,208,0.93 [0.59-1.47],0.76703093982144
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,20076,105,1.65 [0.88-3.11],0.1184897139372097
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,17335,69,0.55 [0.25-1.25],0.1569510492886831
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18335,3996,1.23 [1.11-1.36],0.00012246893483
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17148,2809,1.02 [0.90-1.15],0.7892416038395819
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,17329,63,1.03 [0.44-2.43],0.9472770322456804
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,17689,119,0.89 [0.48-1.65],0.7046785460162228
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,17687,117,1.45 [0.79-2.68],0.2324789000471402
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19927,54,1.21 [0.48-3.04],0.6870525128081213
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",17633,63,0.40 [0.18-0.90],0.0272892326357178
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15070,731,0.89 [0.69-1.14],0.3481553387911735
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19999,124,0.92 [0.51-1.67],0.7910908982072209
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17789,219,0.92 [0.59-1.45],0.7193315399613952
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17112,5239,1.11 [1.01-1.22],0.0294438356383665
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,19230,85,1.53 [0.75-3.11],0.2449540951944909
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,17402,136,1.45 [0.83-2.53],0.1933405601425092
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17642,376,1.39 [0.99-1.96],0.0571320330200633
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19402,1832,1.03 [0.88-1.20],0.7073015800538816
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17582,316,0.77 [0.53-1.12],0.1713939539118582
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,17311,45,2.43 [0.94-6.25],0.0665079621222624
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17347,81,0.72 [0.34-1.53],0.3898527278932749
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19828,26,0.81 [0.22-2.94],0.7448203712930357
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15546,1207,0.96 [0.79-1.17],0.7101740954155491
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,15148,809,3.04 [2.50-3.69],1.8477135876280289e-29
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19979,797,3.21 [2.63-3.92],5.094724823451239e-30
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14377,38,0.76 [0.25-2.26],0.6159492337187255
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14406,67,1.20 [0.53-2.72],0.656582853265762
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17485,219,1.21 [0.77-1.90],0.4119180567912373
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14866,527,1.02 [0.76-1.38],0.8878513230494367
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,17604,34,2.09 [0.68-6.45],0.1978753292069741
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,18006,436,1.02 [0.74-1.41],0.885732281343953
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,17785,215,0.73 [0.46-1.16],0.1803865884521069
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14830,491,1.00 [0.74-1.37],0.9865051128609298
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,17319,53,0.82 [0.33-2.06],0.6783065756539275
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",17307,41,1.33 [0.47-3.76],0.5857234451210485
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,19222,77,1.72 [0.83-3.55],0.1420262304438477
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19859,714,1.00 [0.78-1.28],0.9897436424231156
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19471,326,0.82 [0.57-1.18],0.2867575555096752
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",20034,244,1.18 [0.77-1.80],0.44074111945847
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,15899,1560,1.22 [1.03-1.45],0.0187572224518976
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14385,46,1.02 [0.37-2.80],0.9682492774646052
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,17331,65,1.16 [0.50-2.66],0.7272764259127495
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14385,46,2.04 [0.81-5.11],0.1285245855140781
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14377,38,0.68 [0.22-2.06],0.4957782255682549
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19298,153,1.39 [0.82-2.37],0.2270178183633204
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,19282,137,0.81 [0.46-1.43],0.4652540090496467
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,20070,69,0.68 [0.30-1.52],0.3471587547900351
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18829,1259,0.99 [0.82-1.19],0.8773141097444013
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17319,53,0.76 [0.30-1.94],0.5618623537730458
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14374,35,0.64 [0.33-1.23],0.1822695586437668
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,18085,515,0.80 [0.59-1.07],0.1316929623871849
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15764,1425,1.14 [0.96-1.36],0.1438863241571804
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19847,45,1.21 [0.46-3.20],0.7006107985161361
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,20086,52,2.51 [1.10-5.75],0.0290060289750626
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17336,70,1.34 [0.61-2.94],0.4642281779440464
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",18087,821,0.87 [0.69-1.10],0.25736795805347
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,17343,77,1.42 [0.68-3.00],0.3511534971328247
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15362,1023,1.16 [0.94-1.43],0.1595036543533166
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,19215,70,1.51 [0.69-3.32],0.3057253109844669
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,17304,38,1.43 [0.50-4.12],0.5064573062071434
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,17662,92,1.06 [0.53-2.09],0.8773162523753233
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17685,419,1.24 [0.90-1.70],0.1938230942744985
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19961,159,0.97 [0.57-1.63],0.9068175709559372
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17976,406,1.01 [0.73-1.41],0.946621816050398
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,20042,241,0.96 [0.63-1.47],0.8513817505334237
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,20086,31,1.38 [0.43-4.44],0.5922156787716697
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17395,129,1.45 [0.81-2.60],0.2088885794349486
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16500,474,1.14 [0.84-1.55],0.388456557683395
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17665,399,0.72 [0.52-1.01],0.0581183995697074
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17552,286,0.68 [0.45-1.01],0.0533563155125002
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14364,25,0.88 [0.23-3.37],0.8494752420218745
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16239,1900,1.63 [1.41-1.89],6.305965811213949e-11
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14704,365,1.40 [0.99-1.96],0.0546249460288344
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19934,132,0.99 [0.56-1.74],0.9589107771917716
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",20038,37,0.71 [0.24-2.15],0.5470817445376253
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",18452,35,1.14 [0.39-3.31],0.8131617178160282
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14393,54,2.57 [1.16-5.71],0.0201905753875782
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,17643,73,0.82 [0.38-1.79],0.6179151241787137
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14590,251,1.23 [0.81-1.87],0.3256095737506486
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17508,242,0.98 [0.64-1.51],0.937032501434942
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,17747,177,1.15 [0.70-1.89],0.5834949140810222
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,17640,70,1.02 [0.46-2.26],0.9632480775383444
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,15980,25,0.94 [0.25-3.57],0.9253966944095215
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",20088,33,1.38 [0.44-4.29],0.5805193166841295
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17708,442,0.94 [0.68-1.29],0.6894776722565107
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],19819,17,0.79 [0.43-1.46],0.4480117117533971
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,19185,1919,0.94 [0.81-1.10],0.4352931864893617
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17355,89,1.44 [0.71-2.89],0.3116400123804332
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17976,406,0.84 [0.60-1.17],0.2946106755880808
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,19192,165,1.09 [0.65-1.82],0.7527336397409454
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,17687,117,0.67 [0.36-1.23],0.195109479314188
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,18646,1076,1.14 [0.93-1.39],0.2051525984652623
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,18239,669,1.22 [0.94-1.57],0.1306729666738865
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],17297,31,2.36 [0.79-7.08],0.125615740235944
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19839,37,3.19 [1.23-8.30],0.0174418708568404
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17373,107,1.70 [0.92-3.17],0.0924497964863208
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,17285,19,1.85 [0.44-7.76],0.4024294458046862
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14390,51,0.57 [0.22-1.48],0.2466968519696581
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19356,1501,2.06 [1.74-2.43],2.2348671224121558e-17
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19705,336,1.02 [0.71-1.47],0.9038626092077516
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19491,122,1.19 [0.65-2.16],0.5738634608572044
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18982,1127,4.89 [4.22-5.67],5.337057073457837e-99
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19901,46,13.44 [8.78-20.56],4.942712651301762e-33
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19890,283,1.37 [0.93-2.02],0.110466009835217
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,17749,172,0.98 [0.59-1.63],0.9437616594374711
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Dialysis,17923,68,8.30 [5.72-12.05],9.309259668750663e-29
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19048,2777,1.01 [0.89-1.15],0.827438492671007
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18173,4653,1.20 [1.08-1.32],0.0004065310453569
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19925,70,5.37 [2.99-9.62],1.7547011311600318e-08
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,16440,169,0.53 [0.32-0.89],0.0156279036877099
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,17920,289,2.21 [1.50-3.23],5.029478977785443e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18448,2177,1.06 [0.92-1.23],0.3940829749796067
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16465,194,1.10 [0.68-1.77],0.6979930781371688
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,17635,58,0.67 [0.28-1.62],0.373758584055416
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16371,100,0.61 [0.31-1.18],0.1430185977911873
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",20092,52,0.90 [0.36-2.22],0.8145454788070831
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",20090,44,1.09 [0.40-2.96],0.8646392386450912
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19405,1828,1.04 [0.89-1.21],0.6350777848809195
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,18375,798,0.98 [0.77-1.24],0.8410579900447954
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,20041,434,2.04 [1.51-2.76],3.877923120328542e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16529,258,0.96 [0.63-1.46],0.8496005161122386
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16507,236,1.06 [0.69-1.65],0.779203068336498
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16459,188,1.25 [0.78-2.02],0.3541222904999892
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,20088,41,3.89 [1.71-8.85],0.0011723403121041
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18800,1223,1.10 [0.91-1.33],0.3154232671237508
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17954,323,2.25 [1.57-3.22],1.0016144329837588e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19753,146,2.98 [1.84-4.85],1.0008611829891216e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19907,52,3.72 [1.72-8.07],0.0008790236470166
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16492,221,1.16 [0.74-1.82],0.5086700496295025
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19881,2250,2.36 [2.06-2.69],2.3887268017879174e-36
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",17686,55,2.83 [1.21-6.60],0.0159206816890374
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17970,115,5.53 [3.44-8.90],1.8637175987999906e-12
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19431,62,0.84 [0.35-2.02],0.6999033912529001
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,17822,245,1.24 [0.81-1.90],0.320465441867638
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19808,439,0.99 [0.72-1.36],0.9317392464685232
